Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^* Ugwumba Chidozie	2. Issuer Name and Ticker or Trading Symbol BiomX Inc. [ PHGE ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner _____ Officer (give title below) __X__ Other (specify below) Exit Form 4 - former 10% owner
(Last) (First) (Middle) 609 SW 8TH STREET, SUITE 365	3. Date of Earliest Transaction (MM/DD/YYYY) 8/10/2022
(Street) BENTONVILLE, AR 72712 (City) (State) (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	8/10/2022		S		17769	D	$0.74	3620077 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	8/11/2022		S		9824	D	$0.744	3610253 ⁽¹⁾	I	By Symbiosis, LLC
Common Stock	8/12/2022		S		11406	D	$0.734	3598847 ⁽¹⁾	I	By Symbiosis, LLC
Common Stock	8/15/2022		S		7200	D	$0.747	3591647 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	8/16/2022		S		8563	D	$0.729	3583084 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	8/17/2022		S		21335	D	$0.688	3561749 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	8/18/2022		S		7764	D	$0.683	3553985 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	8/19/2022		S		14600	D	$0.639	3539385 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	8/22/2022		S		5000	D	$0.657	3534385 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	8/23/2022		S		5900	D	$0.638	3528485 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	8/24/2022		S		8665	D	$0.652	3519820 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	8/25/2022		S		26945	D	$0.718	3492875	I	By SymBiosis, LLC
Common Stock	8/26/2022		S		60628	D	$0.616	3432247 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	8/29/2022		S		11533	D	$0.571	3420714 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	8/30/2022		S		13487	D	$0.566	3407227 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	8/31/2022		S		4540	D	$0.549	3402687 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	9/1/2022		S		8297	D	$0.546	3394390 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	9/2/2022		S		2001	D	$0.546	3392389 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	9/6/2022		S		6403	D	$0.545	3385986 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	9/7/2022		S		8846	D	$0.528	3377140 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	9/8/2022		S		4592	D	$0.522	3372548 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	9/9/2022		S		13219	D	$0.518	3359329 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	9/12/2022		S		1700	D	$0.541	3357629 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	9/13/2022		S		2201	D	$0.525	3335428 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	9/14/2022		S		2301	D	$0.523	3353127 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	9/15/2022		S		3900	D	$0.531	3349227 ⁽¹⁾	I	By SymBiosis, LLC

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)			11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:
(1)	The shares are directly held by SymBiosis, LLC.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Ugwumba Chidozie 609 SW 8TH STREET SUITE 365 BENTONVILLE, AR 72712				Exit Form 4 - former 10% owner

Signatures
/s/ Chidozie Ugwumba		11/14/2022
^**Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.